FDANews
www.fdanews.com/articles/193642-cryolife-nabs-ce-mark-for-minimally-invasive-thoracic-stent-graft

CryoLife Nabs CE Mark for Minimally Invasive Thoracic Stent Graft

December 3, 2019

CryoLife earned the CE Mark for its E-nya thoracic stent graft system for minimally invasive repairs of descending thoracic aorta lesions, including thoracic aortic aneurysms and dissections.

The device features different configurations, including bare spring and covered proximal configurations, to give physicians more flexibility and control for simple and complex anatomies.

Most patients with thoracic aortic disease are treated using minimally invasive endovascular stent grafts.

View today's stories